@auwerx-lab.bsky.social

Our new study is out in Nature Medicine! Using human genetic data supports targeting LXR to treat lipid disorders! Thanks to our collaborators, @OrsoBio and @Takanori Takebe. Congrats to Xiaoxu and all colleagues. actu.epfl.ch/news/first-i...

First-in-human drug trial lowers high blood fats

In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug can safely lower triglycerides and other blood lipids.

actu.epfl.ch